[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid

C38H45N5O7 — CID 118292600

IUPAC[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
SMILESCOc1ccc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)C2CCOCC2)c2cc(C#N)ccc21
InChIInChI=1S/C38H45N5O7/c1-23-33(40-34(44)31(20-38(2,3)4)41(5)37(47)48)36(46)42(22-28-27-10-8-7-9-25(27)12-14-32(28)49-6)29-13-11-24(21-39)19-30(29)43(23)35(45)26-15-17-50-18-16-26/h7-14,19,23,26,31,33H,15-18,20,22H2,1-6H3,(H,40,44)(H,47,48)/t23-,31-,33-/m0/s1
InChIKeyNJFDYVPRQOTFTE-ILQUCRJGSA-N
MW683.81 g/mol
LogP5.31
Rot. Bonds8

About [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid

[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid (PubChem CID 118292600) has the molecular formula C38H45N5O7 and a molecular weight of 683.81 g/mol. Its IUPAC name is [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid.

Molecular Properties

Compound Name[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
PubChem CID118292600
Molecular FormulaC38H45N5O7
Molecular Weight683.81 g/mol
Exact Mass683.33
IUPAC Name[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
SMILESCOc1ccc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)C2CCOCC2)c2cc(C#N)ccc21
InChIInChI=1S/C38H45N5O7/c1-23-33(40-34(44)31(20-38(2,3)4)41(5)37(47)48)36(46)42(22-28-27-10-8-7-9-25(27)12-14-32(28)49-6)29-13-11-24(21-39)19-30(29)43(23)35(45)26-15-17-50-18-16-26/h7-14,19,23,26,31,33H,15-18,20,22H2,1-6H3,(H,40,44)(H,47,48)/t23-,31-,33-/m0/s1
InChIKeyNJFDYVPRQOTFTE-ILQUCRJGSA-N
XLogP5.31
TPSA152.51 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500683.81
LogP ≤ 55.31
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The IUPAC name of [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid (CID 118292600) is [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid.
What is the SMILES notation for [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The canonical SMILES for [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid is COc1ccc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)C2CCOCC2)c2cc(C#N)ccc21.
What is the InChIKey of [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The InChIKey is NJFDYVPRQOTFTE-ILQUCRJGSA-N. The full InChI is InChI=1S/C38H45N5O7/c1-23-33(40-34(44)31(20-38(2,3)4)41(5)37(47)48)36(46)42(22-28-27-10-8-7-9-25(27)12-14-32(28)49-6)29-13-11-24(21-39)19-30(29)43(23)35(45)26-15-17-50-18-16-26/h7-14,19,23,26,31,33H,15-18,20,22H2,1-6H3,(H,40,44)(H,47,48)/t23-,31-,33-/m0/s1.
What are the key properties of [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
[(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid has a molecular weight of 683.81 g/mol, XLogP of 5.31, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-5-(oxane-4-carbonyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid is sourced from PubChem (CID 118292600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).